Covid-19
Vaccine Journal: Published: February, 2024A multinational Global Vaccine Data
Network (GVDN) cohort study of 99 million vaccinated individuals.This study aimed to evaluate the
risk of adverse events (13 medical conditions) of special interest (AESI)
following COVID-19 vaccination from 10 sites across 8 countries. Most vaccine
recipients were in...
The World Health Organization (WHO) classified the sub-variant
of the Omicron strain JN.1 as a "variant of interest",because of
"its rapidly increasing spread".JN.1 has been found in many countries around the world,
including India, China, UK and the United States.TAKE HOME MESSAGEIt is descended from the BA.2.86 (Pirola) variant.It appears able...
Clinical Neurophysiology: April 2023Long term symptoms following
COVID-19 (Long COVID) now affects a large number of patients with estimates of
up to 100 million people world-wide.Prolonged “long-COVID” (P-L–COVID),
seen several months after even a mild COVID-19 infection, is characterized by a
complexity of neuromuscular, musculoskeletal, and...
Omicron subvariant XBB.1.16, the strain was first identified in January and has been monitored by the World Health Organisation (WHO) since 22 March, which upgraded it to a “variant of interest” in mid-April.Cases of Omicron variant XBB are mounting in China, forming a new wave expected to crest around 65 million cases...
JAMA: The Journal of the American Medical Association: Published on
November, 2022Despite advances in treatment of
COVID-19, additional therapies are needed, particularly in the outpatient
setting. Novel oral antivirals have been authorized for high-risk individuals. Numerous
repurposed drugs have been investigated for COVID-19.Ivermectin, an a...
Nature Medicine and The British Medical Journal (BMJ): Published July, 2022Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection is associated with a range of persistent symptoms impacting everyday
functioning, known as post-COVID-19 condition or long COVID.People experiencing long covid have reported a wider set of
symptoms tha...
JAMA Network: November, 2022After the worldwide outbreak
leading to millions of acute cases and thousands of deaths, another important
development is the occurrence or persistence of symptoms after the acute phase
of SARS-CoV-2 infection (ie, long COVID or post–COVID-19).More than 100 post–COVID-19
symptoms affecting multiple systems (eg, cardi...
The persistence, severity, and disability associated with post-COVID conditions, often referred to as "long COVID," pose significant diagnostic and management challenges. Some patients who have been infected with SARS-CoV-2, the virus that causes COVID-19, have new, recurring, or ongoing symptoms and clinical findings four or more weeks after infec...
The persistence, severity, and disability associated with post-COVID conditions, often referred to as "long COVID," pose significant diagnostic and management challenges. Some patients who have been infected with SARS-CoV-2, the virus that causes COVID-19, have new, recurring, or ongoing symptoms and clinical findings four or more weeks after infec...
NICE guidelines: The holistic assessment, investigation, and management approach suggested by NICE are outlined here.Pulmonary Symptoms ManagementInvestigations:Pulmonary symptoms are common during long covid. NICE recommends that breathlessness may be investigated using an exercise tolerance test suited to the person’s ability, for example the one...
Neurology (American Academy of Neurology) Journal: Published on March,
2022Severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) can cause long-term disability (long COVID)
with new neurologic manifestations after even mild infections. Reports of peripheral
neuropathy include Guillain-Barré syndrome, mononeuritis multiplex, brachial
ple...
Obstetrics and Gynecology Journal: Published in September, 2022Vaccination against coronavirus
disease 2019 is safe and effective at preventing illness, including hospitalization
and death due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections,
and booster and additional primary dose COVID-19 vaccinations increase
protec...
